US Stock MarketDetailed Quotes
CRBU Caribou Biosciences
- 2.200
- +0.180+8.91%
Close Nov 27 16:00 ET
199.22MMarket Cap-1325P/E (TTM)
2.200High2.000Low2.11MVolume2.040Open2.020Pre Close4.48MTurnover2.58%Turnover RatioLossP/E (Static)90.55MShares8.33052wk High0.71P/B179.47MFloat Cap1.50052wk Low--Dividend TTM81.58MShs Float32.645Historical High--Div YieldTTM9.90%Amplitude1.500Historical Low2.127Avg Price1Lot Size
About Caribou Biosciences Company
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Company Profile
SymbolCRBU
Company NameCaribou Biosciences
Listing DateJul 23, 2021
Issue Price16.00
Founded2011
CEODr. Rachel Haurwitz, PhD
MarketNASDAQ
Employees158
Fiscal Year Ends12-31
Address2929 7th Street,Suite 105
CityBerkeley
ProvinceCalifornia
CountryUnited States of America
Zip Code94710
Phone1-510-982-6030
Websitehttp://www.cariboubio.com
Company Executives
- Name
- Position
- Salary
- Dr. Rachel Haurwitz, PhD
- President, Chief Executive Officer and Director
- 3.12M
- Ruhi Ahmad Khan
- Chief Business Officer
- --
- Barbara G. McClung, J.D.
- Chief Legal Officer and Corporate Secretary
- 1.22M
- Tim Kelly
- Chief Technology Officer
- --
- Dr. Steven B. Kanner, PhD
- Chief Scientific Officer
- 1.22M
- Ryan Fischesser
- Principal Accounting Officer, Vice President, Finance and Controller
- --
- Andrew L. Guggenhime
- Chairman of the Board
- 202.74K
- Dr. Dara Richardson-Heron
- Independent Director
- 141.93K
- David L. Johnson, C.P.A.
- Independent Director
- 143.85K
- Dr. Natalie Sacks
- Independent Director
- 136.99K
- Ran Zheng
- Independent Director
- 157.20K
- Dr. Scott Braunstein, M.D.
- Independent Director
- 155.86K
- Dr. Nancy C. Whiting, Pharm.D.
- Independent Director
- 140.62K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
